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wide differentiation potential. [ 1 ] To har-
vest the regenerating potential of the 
stem cells, advanced materials should 
be designed to present the key signals of 
the natural cellular microenvironment to 
the stem cells and direct their differen-
tiation. [ 2 ] Growth factors (GFs) are crit-
ical chemical signals in the extracellular 
matrix (ECM), which are activated during 
tissue development or repair to regulate 
cell migration, adhesion, proliferation, 
and differentiation. [ 3 ] To effectively regu-
late stem cells, GFs should reach the cells 
without denaturing and remain there for 
a suffi cient time period. [ 4 ] Therefore, con-
trolled spatiotemporal presentation of 
GFs is desired in regulating stem cells for 
tissue regeneration. [ 5 ] 
 Tethering GFs on biomaterials is a 
promising strategy to deliver sustained 
and localized GF signals to cells. [ 6 ] Similar 
to ECM where GFs such as Transforming 
Growth Factor-β1 (TGF-β1) and Bone Mor-
phogenetic Protein-2 (BMP-2) are bound 
and localized, [ 7 ] synthetic scaffolds may 
also be tethered with GFs to deliver sus-
tained signals to the local cells. The immo-
bilization of GFs could slow down their degradation/internali-
zation rate. [ 8 ] Compared to the delivery of soluble GFs through 
adsorption or encapsulation into biodegradable polymers, [ 9 ] 
covalent immobilization may likely reduce burst release that 
might cause toxicity to cells, [ 10,11 ] and prevent GF diffusion to 
unintended surrounding tissues, which might cause compli-
cations. [ 12 ] However, the conformation of GFs could be com-
promised during the covalent binding reactions, resulting in 
reduced bioactivity. [ 13 ] 
 Alternatively, covalently tethering GF-mimicking short 
peptides instead of the entire GF onto biomaterials is likely 
advantageous. [ 14 ] These GF-mimicking peptides, derived from 
GFs or discovered by screening techniques, are able to recog-
nize the corresponding GF receptors, trigger associated signal 
transduction and lead to similar cell responses to those by the 
native GFs. [ 15–19 ] Unlike GFs which require a tertiary structure 
for activity, these GF-mimicking peptides typically have a sub-
stantially smaller molecular size and a linear structure, so that 
bioactivity can be well retained after chemical reactions. [ 16,17,19,20 ] 
However, the use of these GF mimics for stem cell regula-
tion and tissue regeneration remains largely unexplored [ 16,20 ] 
because of the lack of appropriate ways to present them on 
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 1.  Introduction 
 Stem cells are an excellent cell source for engineering human 
tissue substitutes because of their fast proliferation rate and 
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3D scaffolds. For example, Cytomodulins (CM) are a family of 
TGF-β1 mimicking peptides. Like TGF-β1, CM can enhance 
the expression of collagen I and improve wound healing effect 
of fi broblasts. [ 18,19 ] However, unlike TGF-β1, the soluble form of 
CM peptides cannot effectively induce chondrogenic differen-
tiation of stem cells. [ 21 ] We hypothesized that ECM-mimicking 
scaffolds would enhance the bioactivity of bound GF-mimicking 
peptides in directing stem cell differentiation. This study was 
designed to develop an advanced injectable ECM-mimicking 
scaffold and evaluate its effi cacy in enhancing bioactivity of the 
bound GF-mimicking peptides. 
 To mimic the physical structure of collagen in extracel-
lular matrix (ECM), synthetic nanofi bers have been developed, 
which are found to improve stem cell attachment, proliferation, 
and differentiation along various lineages when appropriate 
biochemical cues such as GFs are present. [ 22,23 ] Therefore, 
we specifi cally hypothesized that nanofi bers are excellent 
substrates for GF-mimicking peptides, and the conjuga-
tion may synergize the geometrical cues and the chemical 
cues to enhance the effi cacy of GF-mimicking peptides. 
Current approaches to fabricating functional nanofi bers include 
the self-assembly of peptide amphiphiles into nanofi bers, [ 24 ] 
electrospinning of nanofi bers from functional polymers, [ 25 ] and 
surface modifi cation of nanofi bers after electrospinning. [ 25 ] 
However, these approaches toward tissue engineering applica-
tions have been primarily limited to in vitro studies due to the 
diffi culty in generating controllable 3D pore structures. [ 25 ] While 
novel phase-separation techniques have been shown capable of 
generating nanofi brous materials with  well-controlled 3D pore 
structure, [ 26 ] these porous 3D scaffolds are not injectable and 
cannot be used for minimally invasive procedures to regenerate 
small and irregularly shaped tissue defects. Our laboratory 
recently developed injectable polymeric nanofi brous hollow 
microspheres (NF-HMS), [ 27 ] which, however, lack functional 
groups for conjugating biomolecules. 
 In this work, we successfully synthesized a novel function-
alized graft copolymer that can self-assemble into functional 
nanofi brous hollow microspheres (FNF-HMS) and conjugate 
biomolecules such as peptides. The NF structure of the FNF-
HMS presents the geometrical features of collagen in natural 
ECM, which may enhance the effi cacy of GF signals in stem 
cell differentiation. [ 28 ] Two different GF mimics, a TGF-β1 
mimicking peptide CM10 and a BMP-2 mimicking peptide 
P24, were separately conjugated onto the novel FNF-HMS, and 
were evaluated for enhancing cartilage and bone regeneration, 
respectively. 
 2.  Results 
 2.1.  Functionalizing PLLA-based Copolymers with Acrylic 
Groups 
 Poly( L -lactic acid) (PLLA) is among the few Food and Drug 
Administration (FDA) approved synthetic materials for 
 certain human clinical applications (e.g., degradable sutures, 
stents, wound dressings), which has been widely used as syn-
thetic polymeric materials in scaffold fabrication. [ 29 ] However, 
PLLA lacks functional groups for biomolecule conjugation. 
Here, we synthesized a series of PLLA-based graft copoly-
mers poly( L -lactic acid)-graft-poly(hydroxyethyl methacrylate) 
(PLLA-g-PHEMA) to introduce PHEMA blocks to PLLA for 
the conjugation of peptides or proteins. The schematic syn-
thesis procedure is illustrated in  Figure  1 . Briefl y, hydroxyethyl 
methacrylate (HEMA) was fi rst used as the initiator for the 
ring-opening polymerization of  L -lactide to synthesize mac-
romonomer MACRO-PLLA. The macromonomer MACRO-
PLLA was then copolymerized with HEMA (which served as 
monomers in this step) through free radical polymerization to 
synthesize PLLA-g-PHEMA. [ 30 ] The hydroxyls in PHEMA block 
were then converted into acrylic groups through their reac-
tion with methacrylic anhydride using DMAP/TEA chemistry, 
forming PLLA-g-PHEMA-acrylic. The chemical structures of 
these materials were confi rmed by  1 H-Nuclear Magnetic Reso-
nance spectroscopy (Figure S1–3, Supporting Information). 
Advantageously, PLLA-g-PHEMA-acrylic is also biodegradable. 
Therefore, we have successfully synthesized biodegradable and 
functionalized PLLA-based copolymers for the fabrication of 
functional NF-HMS (FNF-HMS). 
 2.2.  Fabrication of FNF-HMS from PHEMA-g-PLLA-acrylic 
 An important advantage of the newly synthesized  functional 
block copolymers is their capability to self-assemble into 
advanced structures at multiple scales. When subjected to 
emulsifi cation, phase separation, solvent extraction and 
freeze-drying processes, [ 27 ] the block copolymers self-assembled 
into functional nanofi brous hollow microspheres (FNF-HMS) 
( Figure  2 ). Experimentally, the polymer was fi rst dissolved in 
tetrahydrofuran (THF) at a concentration of 2% w/v at 50 °C. 
Glycerol was then added gradually to emulsify the polymer 
solution into liquid microspheres via rigorous stirring at 
50 °C. Because a relative large amount of glycerol (more 
than three times the volume of the polymer solution) was 
gradually added into the rigorously stirred polymer solu-
tion, the initially dispersed phase of glycerol in the polymer 
solution transitioned into the continuous phase. This 
phase inversion led to the formation of “water-in-oil-in-
water” (W/O/W) type double emulsion (glycerol-in-Polymer/
THF-in-glycerol) (Figure  2 A). Although double emulsions 
are generally unstable, the block copolymers were believed 
to self-assemble to lower the associated free energy at the 
W/O/W interfaces and stabilize the double emulsions. Upon 
quenching in liquid nitrogen and the subsequent extraction 
of the solvent and glycerol, double emulsions became hollow 
microspheres. 
 The structure of the formed microspheres was character-
ized using scanning electron microscopy (Figure  2 B-D). At 
the nano-scale, the copolymers were thermally induced to 
phase separate into nanofi bers (diameters ranging from 50 to 
500 nm), mimicking the ECM collagen fi ber structure. At the 
micro-scale, FNF-HMS had a hollow structure with an opening 
on the shell (which is approximately 20 µm in diameter). This 
hollow structure can not only lower the density of the scaffold 
for faster degradation, but also facilitate cell seeding inside the 
microspheres for more robust tissue  formation. At the macro-
scale, the microsphere suspension is injectable, facilitating 
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the regeneration of irregularly shaped tissue defects through 
minimally invasive procedures. These data demonstrated for 
the fi rst time that these branched copolymers (instead of star-
shaped polymers) are able to form FNF-HMS with desirable 
structures as cell carriers for tissue engineering. 
 2.3.  Establish “Thiol-ene” Click Reaction Between Biomolecules 
and FNF-HMS 
 In addition to the self-assembly capabilities at multiple scales, the 
novel functional block copolymers can facilitate bioconjugation 
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 Figure 1.  Synthesis route of functional PLLA-based block copolymer PHEMA-g-PLLA-acrylic.
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with thiolated peptides through “thiol-ene” click reaction. To facili-
tate the click reaction, an additional cysteine (with one thiol side 
group) was added to the C-terminal of the selected peptides. The 
click reaction was performed through the nucleophile-mediated 
process due to its mild reaction conditions at room tempera-
ture. [ 31 ] Tris(2-carboxyethyl)phosphine (TCEP) is employed as the 
nucleophile, which is also a reducing agent and can prevent the 
disulfi de bonding between peptides. [ 32 ] Due to the mild reaction 
conditions, the physical structure of FNF-HMS was unchanged 
after the click reaction (Figure S4, Supporting Information). 
 To visualize the conjugation sites and distribution of the con-
jugated molecules, fl uorescent moieties were conjugated with 
FNF-HMS for confocal imaging and observation ( Figure  3 ). 
Experimentally, thiol-PEG-biotin was conjugated to FNF-HMS, 
which subsequently bound FITC-tagged avidin through biotin-
avidin interaction (Figure  3 A). Therefore, fl uorescent signals 
were emitted from the conjugation sites. To minimize staining 
background due to non-specifi c binding of FITC-tagged avidin 
to FNF-HMS, the biotin-conjugated FNF-HMS were incu-
bated with 10% bovine serum albumin (BSA) solution prior to 
the biotin-avidin conjugation. According to confocal imaging 
(Figure  3 B,C), the avidin-tagged FNF-HMS exhibited fl uores-
cent signals throughout the shell of the microspheres, indi-
cating that the conjugated moieties were distributed on the 
entire FNF-HMS. When FNF-HMS without biotin conjugation 
were subjected to the same procedures (in BSA solution and 
then mixed with FITC tagged avidin), no fl uorescent signals 
were emitted from FNF-HMS, indicating that specifi c binding 
of FITC-avidin to FNF-HMS occurred. 
 Advantageously, the developed FNF-HMS can conjugate 
controllable amount of peptides to present different concen-
trations of ligands to cells ( Figure  4 A). This was achieved 
by adjusting the density of acrylic groups in the copolymers 
during the molecular synthesis. Specifi cally, a higher feeding 
ratio of HEMA to macromonomer (MACRO-PLLA) during the 
copolymerization step (Figure  1 ) will produce copolymers with 
a higher density of hydroxyls from the PHEMA blocks. Upon 
the conversion of hydroxyls into acrylic groups, the copolymer 
with a higher HEMA to MACRO-PLLA ratio will present a 
higher density of acrylic groups for conjugating more  peptides 
(Figure  4 A). For simplicity, we defi ne  AD (acrylic group 
 density) to be the molar feeding ratio of HEMA to MACRO-
PLLA during the copolymerization. Therefore, FNF-HMS 
fabricated from copolymers with a high  AD can conjugate 
more peptides. 
 To demonstrate our control over conjugation densities, FNF-
HMS were fabricated from copolymers with different  AD values 
( AD = HEMA/ MACRO-PLLA = 0.8, 0.9, and 0.95) for peptide 
conjugation. An excess amount of peptide CM10 was used for 
the conjugation with FNF-HMS to ensure a high conversion 
of acrylic groups. The peptide immobilized FNF-HMS was 
fi rst qualitatively analyzed using Fourier Transform Infrared 
Spectroscopy (FTIR) (Figure  4 B). According to FTIR, peaks at 
1601.3 and 1641.5 cm −1 disappeared after the click reaction, 
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 Figure 2.  a) A schematic illustration showing the emulsifi cation and phase separation techniques to fabricate FNF-HMS. b–d) SEM micrographs of 
FNF-HMS fabricated from a PHEMA-g-PLLA-acrylic copolymer.
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indicating that most of the acrylic groups on FNF-HMS were 
reacted. The conjugation was then evaluated quantitatively by 
amino acid analysis. As expected, FNF-HMS with a higher 
 AD value conjugated more CM peptides (Figure  4 C). FNF-
HMS with an  AD of 0.8 can conjugate peptides at a density of 
1.53 nmol/µg, while FNF-HMS with an  AD of 0.95 can conju-
gate peptides at a density of 11.16 nmol/µg. Therefore, we can 
control the peptide density on FNF-HMS through the manipu-
lation of copolymer composition. 
 2.4.  CM Conjugated FNF-HMS for Cartilage Regeneration 
 Cytomodulin (CM) is a family of TGF-β1 mimicking pep-
tides. [ 18,19,33 ] We selected a chondrogenic peptide CM10 
(LIANAK) from the CM peptide family, conjugated it onto the 
developed FNF-HMS. To facilitate the conjugation of CM10 
onto FNF-HMS, an additional cysteine was incorporated at the 
C-terminal of CM10 (therefore with an amino acid sequence 
of LIANAKC). In order to test the bioactivity of the conju-
gated CM10, FNF-HMS with or without CM10 were mixed 
with rabbit bone marrow-derived stem cells (BMSCs), and the 
in vitro chondrogenic differentiation of the stem cells and in 
vivo cartilage regeneration were examined. Rabbit BMSCs were 
selected because of their capability to differentiate along several 
lineages including chondrogenesis and osteogenesis. 
 In the in vitro study, FNF-HMS ( AD = 0.9) with or without 
CM10 conjugation were cultured with rabbit BMSCs in DMEM 
without TGF-β1 for 3 weeks and the formed tissue constructs 
were examined using Safranin-O staining. Chondrogenic dif-
ferentiation of BMSCs and typical cartilage formation were con-
fi rmed by positive Safranin-O staining for glycosaminoglycans 
(GAG) in the CM10-FNF-HMS group ( Figure  5 A,B), while no 
obvious cartilage-like tissue was found in the control FNF-HMS 
group without CM10 (Figure  5 C,D). Therefore, we confi rmed 
that CM10 peptide, after being conjugated onto FNF-HMS, 
remained biologically active and induced the chondrogenic 
 differentiation of BMSCs in vitro. 
 In the in vivo study, FNF-HMS ( AD = 0.9) with or without 
CM10 conjugation were used as rabbit BMSC carriers for 
 subcutaneous injection in mice. In the CM10-FNF-HMS group, 
cartilage formation was observed after injection for 2 weeks, 
demonstrated by strong safranin-O staining for GAG and immu-
nohistochemical staining for collagen type II ( Figure  6 a,b). No 
obvious mineralization was noticed inside the tissue, revealed by 
negative von Kossa staining (Figure  6 c). In contrast, no  cartilage 
was formed in the control FNF-HMS group without CM10, 
revealed by the negative Safranin-O staining for GAG and neg-
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 Figure 3.  a) A schematic picture of the thiol-ene click reaction between FNF-HMS and thiol-PEG-biotin, and the subsequent binding with FITC-tagged 
avidin. b) A cross-sectional confocal image of FNF-HMS after fl uorescent tagging of the conjugation sites. c) A cross-sectional confocal image of 
fl uorescent-tagged FNF-HMS at a higher magnifi cation, indicating that the click reaction occurred throughout the shells of FNF-HMS.
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ative immunohistochemical staining for collagen II (Figure  6 d,e). 
Similarly, no obvious mineralization was observed according 
to the negative von Kossa staining (Figure  6 f). Therefore, his-
tological analysis following 2 weeks of subcutaneous injection 
revealed that TGF-β1 mimicking peptide CM10 conjugated onto 
FNF-HMS remained bioactive and induced chondrogenic differ-
entiation of rabbit BMSCs and ectopic cartilage formation. 
 2.5.  P24 Conjugated FNF-HMS for Bone Regeneration 
 The BMP-2 mimicking peptide P24 is known to promote osteo-
genesis. [ 17,34 ] In this study, BMP-2 mimicking peptide P24 was 
also conjugated onto the newly developed FNF-HMS to evaluate 
the capacity of the P24-decorated FNF-HMS in inducing stem 
cell osteogenesis and bone regeneration. Experimentally, FNF-
HMS ( AD = 0.9) with or without peptide P24 
were mixed with rabbit BMSCs and injected 
subcutaneously into nude mice. The speci-
mens were harvested 5 weeks after injection 
and were examined histologically for new 
bone formation. H&E staining revealed that 
P24- FNF-HMS supported robust, uniform 
bone formation throughout the specimen 
( Figure  7 a). In the control group (blank 
FNF-HMS), there was signifi cantly less and 
non-uniform bone formation (Figure  7 d). 
While there was a very thin layer of bone 
tissue formation on the outer surface of 
the control specimen, likely benefi ted from 
the access to the host vasculature in these 
regions, there was only sparse bone nodule 
formation in the interior of the harvested 
tissue construct. Consistently, immunohis-
tochemical staining showed a higher level of 
osteocalcin (a late marker of osteogenesis) [ 35 ] 
in the P24-FNF-HMS group (Figure  7 b) 
than in the control FNF-HMS group 
(Figure  7 e). Furthermore, there were more 
and uniform mineralized domains (black) 
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 Figure 5.  Chondrogenic differentiation of BMSCs were demonstrated by positive SO staining 
for GAG in CM10-FNF-HMS/BMSCs group (a,b). The differentiated cells appeared round 
and encased in chondrocytic lacunae. Comparatively, in control group (FNF-HMS) (c,d), the 
staining was weak and no obvious cartilage-like tissue was found. In the high magnifi cation 
images (b,d), arrows are used to indicate FNF-HMS with cells inside. Scale bar: 100 µm.
 Figure 4.  a) A schematic illustration showing the control over the density of functional acrylic groups ( AD value) presented on the surface of FNF-HMS 
via the manipulation of copolymer compositions (HEMA block percentage). A higher HEMA block percentage ( AD value) leads to a higher density of 
functional groups presented on the surface of FNF-HMS, and thus a higher density of peptides that can be conjugated. b) FITC spectrum of FNF-HMS 
before and after conjugation with CM10 peptides, showing the disappearance of peaks corresponding to acrylic groups (circled). c) Amino acid analysis 
of CM10-FNF-HMS at different conjugation densities.
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in the P24-FNF-HMS group (Figure  7 c) than in the control 
FNF-HMS group (Figure  7 f), revealed by von Kossa staining. 
All of the above results consistently indicate that the conjugated 
P24 on the FNF-HMS is biologically functional and shows sim-
ilar osteogenic properties to BMP-2 in inducing osteogenic dif-
ferentiation of rabbit BMSCs and the subsequent ectopic bone 
formation. 
 3.  Discussion 
 Injectable microspheres can serve as cell carriers for tissue 
engineering. To deliver stem cells for regeneration, the micro-
spheres should guide stem cells through the presentation of 
critical physical and chemical signals similar to those in the nat-
ural extracellular microenvironment. In natural ECM, collagen 
is the most abundant protein surrounding cells in the form 
of nanofi bers, where GFs are bound. This complex structure 
may provide both physical cues and chemical stimuli to stem 
cells during development and wound healing. The delivery of 
potent growth factors is likely critical to the success of stem cell 
therapy, where nanofi bers are likely an advantageous matrix 
structure for growth factor presentation. [ 10,23,36 ] However, there 
has been no reported technology that can integrate synthetic 
NF structure and GF signals in injectable microspheres. 
 Recently, a novel technique has been developed to combine 
thermally induced phase separation with emulsifi cation to 
generate nanofi brous hollow microspheres (NF-HMS). [ 27 ] The 
nanofi bers (with an average diameter of about 160 nm) in the 
fabricated microspheres mimic the structural feature of  collagen 
fi bers at the nano-scale, and have a much higher porosity and 
surface area than those of traditional smooth  surface micro-
spheres. [ 27 ] While linear PLLA can only form nanofi brous 
microspheres without a hollow core using this technique, star-
shaped PLLA can self-assemble into nanofi brous microspheres 
with a hollow core (NF-HMS) and openings on the shell of the 
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 Figure 6.  Hyaline cartilage formation after 2 weeks subcutaneous implantation was demonstrated by positive SO staining for GAG and immunohis-
tochemical staining for collagen type II (COL II) in the CM10-FNF-HMS/BMSCs group (a&b). No obvious mineralization was observed using von 
Kossa staining (c). In comparison, negative SO and immunohistochemical staining were seen in FNF-HMS/BMSCs group (d,e). There was no obvious 
mineralization in FNF-HMS/BMSCs group either (f). In image (b), arrows are used to indicate FNF-HMS with cells inside. Scale bar: 100 µm.
 Figure 7.  Histological analysis after 5 w mouse subcutaneous injection of BMP2-mimic P24 conjugated FNF-HMS (P24- FNF-HMS) or control 
FNF-HMS with rabbit BMSCs. P24- FNF-HMS reveal signifi cantly more mature bone formation after 5 w, shown by A) H&E staining, B) osteocalcin 
immunohistochemical staining, and C) von Kossa staining for mineralization, compared to FNF-HMS (D–F). Scale bar: 100 µm.
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spheres. Desirably, the hollow structure of NF-HMS leads to an 
even higher porosity and provides more space for cell growth, 
ECM deposition, nutrient/waste transfer, and minimization of 
degradation products. [ 27 ] The star-shaped molecular structure 
and the hydroxyl end groups on the SS-PLLA are considered 
important features for the assembly of NF-HMS. However, 
such an SS-PLLA lacks functional groups for biomolecule 
conjugation, limiting the presentation of biological signals on 
the NF-HMS assembled from such an SS-PLLA and therefore 
limiting their capacity of directing stem cell differentiation and 
tissue regeneration. 
 In this study, we have synthesized a series of novel PLLA-
based functional graft copolymers PHEMA-g-PLLA-acrylic for 
the fabrication of functional NF-HMS (FNF-HMS) that allows 
GF immobilization. These graft copolymers, with the introduc-
tion of HEMA block onto PLLA, remain biodegradable and 
can be thermally induced to phase separate into nanofi bers. [ 30 ] 
Importantly, PHEMA-g-PLLA-acrylic can self-assemble into 
FNF-HMS during emulsifi cation and phase separation pro-
cedures. We have demonstrated that PHEMA-g-PLLA-acrylic, 
similar to SS-PLLA, can stabilize double emulsions and form 
hollow microspheres, likely due to their hyper-branched molec-
ular structure as well as hydroxyl groups from the HEMA 
blocks. Therefore, we have developed a new type of functional 
polymers to self-assemble into FNF-HMS, which enable us to 
introduce biological signals onto them for tissue regeneration. 
 FNF-HMS assembled from PHEMA-g-PLLA-acrylic have 
been shown capable of conjugating GF-mimicking  peptides 
through “thiol-ene” click reaction for localized and sus-
tained presentation of biological signals. Advantageously, the 
 “thiol-ene” click reactions are orthogonal, tolerant to the pres-
ence of oxygen or water, and can proceed at an extremely high 
reaction rate with quantitative yields in highly polar solvents 
(such as water) in the absence of catalyst, [ 37 ] which is desired 
for medical applications. While the conjugation can be per-
formed prior to scaffold fabrication, we prefer to conjugate 
GF-mimicking peptides to the polymer following microsphere 
assembly. Through this strategy, the conjugation will occur only 
at the surface of the nanofi bers where cell-matrix interactions 
take place. In addition, thiolated biomolecules can be conveni-
ently mixed with FNF-HMS for conjugation prior to use, which 
allows for quick and easy  examination of various biomolecules 
on FNF-HMS for tissue engineering or other applications. 
 Furthermore, the conjugation densities can be easily controlled 
through the molecular  synthesis of the functional copolymer 
(Figure  4 ). Copolymers with a higher AD value can conju-
gate a large amount of the peptide to present more concen-
trated signals to cells if desired. Therefore, targeted dosing of 
GF-mimicking peptides can be easily presented at the surface 
of the developed FNF-HMS. 
 GF mimics conjugated FNF-HMS, combining biochemical 
signals from GF mimics and nano-topographical features of 
nanofi bers, are demonstrated to be highly advantageous in 
modulating stem cells for tissue regeneration in this work. 
The novel peptide-decorated FNF-HMS have advantageous 
properties for tissue regeneration in several aspects. First, the 
NF structure facilitates cell attachment, [ 22 ] which likely facili-
tates the interactions between the immobilized GF mimics 
and the receptors on the stem cells. Second, the density of 
the localized GF signals (i.e., the dosing of GF mimics) can 
be utilized to manipulate the cell-ligand interactions. Third, 
GF signaling molecules, immobilized on FNF-HMS, can pro-
vide sustained interactions with the attached cells due to their 
slower degradation or internalization by cells. [ 8 ] Fourth, unlike 
soluble GFs that might diffuse to the unintended surrounding 
tissues, [ 12 ] tethered GFs only affect the adhered cells/tissues, 
minimizing undesired ectopic complications. Lastly, the high 
porosity and injectability of FNF-HMS allow for fast micro-
sphere  degradation and tissue repair in irregularly shaped 
defects through a  minimally invasive surgical procedure. 
 While the injectable FNF-HMS are novel and capable of 
localized delivery of GF-mimicking peptides, an important 
question was whether the GF-mimicking peptides were bioac-
tive after conjugation and whether the peptide-decorated FNF-
HMS could induce the aimed tissue regeneration. In this study, 
two different GF-mimicking peptides were conjugated onto 
the FNF-HMS and their potentials to induce the respective 
cartilage and bone regeneration were evaluated. While it was 
reported that soluble TGF-β1 mimicking CM peptides were not 
able to induce chondrogenic differentiation of stem cells, [ 21 ] 
we showed that CM conjugated FNF-HMS effectively induced 
BMSC chondrogenesis in both in vitro and in vivo studies. This 
could be attributed to the following advantages of using FNF-
HMS for cartilage regeneration. First, the nanofi bers of FNF-
HMS could induce the chondrocyte phenotype and promote 
the early chondrogenic commitment of BMSCs. This was sup-
ported by our previous observation that cells showed a rounded 
shape on nanofi bers, which is indicative of the chondrocyte 
phenotype and the commitment of the stem cells to the chon-
drogenic lineage. [ 28 ] Second, the 3D culture of BMSCs on FNF-
HMS might support a long-term cartilaginous development. 
Different from a 2D cell culture, FNF-HMS allowed BMSCs to 
attach three-dimensionally, which further facilitated the chon-
drocyte phenotype and chondrogenesis (Figure S5, Supporting 
Information). These results support that FNF-HMS provide 
synergistic effect with TGF-β1 signals to effectively promote 
BMSCs chondrogenesis. In addition to TGF-β1mimicking pep-
tides, the BMP-2 mimicking peptide (P24) was conjugated onto 
the FNF-HMS and was shown to enhance BMSC osteogenesis 
and bone formation. Therefore, the FNF-HMS are likely an 
advanced delivery vehicle for a variety of GF-mimicking pep-
tides. In the future, FNF-HMS will be utilized to deliver more 
types of peptides, biomolecules and their various combinations 
for diagnostic and therapeutic applications. For instance, FNF-
HMS conjugated with different peptides/biomolecules can be 
mixed, or multiple peptides/biomolecules can be conjugated 
onto the same FNF-HMS to achieve co-delivery. Such strategies 
aim to coordinate multiple biological signals to synergize their 
biological effects for the intended applications. 
 4.  Conclusion 
 In this study, we have successfully developed novel FNF-HMS, 
which can conjugate GF-mimicking peptides with retained 
 bioactivity, recapitulating both the geometrical and biochemical 
aspects of natural cell microenvironment to modulate stem 
cell fate. Desirably, these FNF-HMS allow the delivery of stem 
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cells through injection to repair tissue using minimally inva-
sive procedures. Two different GF-mimicking peptides were 
conjugated onto the newly developed FNF-HMS, and both 
conjugated peptides were shown biologically active in directing 
the stem cells along their respective differentiation pathways. 
When the TGF-β1 mimicking peptide was conjugated onto the 
FNF-HMS, the injectable cell carrier induced chondrogenic 
differentiation of BMSCs and cartilage formation. When the 
BMP-2 mimicking peptide was conjugated onto the FNF-HMS, 
the injectable cell carrier induced osteogenic differentiation 
of BMSCs and bone formation. The NF structure appeared to 
enhance the effi cacy of the GF-mimicking peptides in stem cell 
fate regulation. The new FNF-HMS therefore can serve as an 
advanced and versatile injectable carrier platform. In the future, 
FNF-HMS may be utilized to present or deliver a variety of pep-
tides/biomolecules in various combinations for diagnostic and 
therapeutic applications. 
 5.  Experimental Section 
 Materials : Tetrahydrofuran (THF) and glycerol were purchased 
from Aldrich Chemical (Milwaukee, WI). (3s)-cis-3,6-dimethyl-1,
4-dioxane-2,5-dione ( L -lactide) was purchased from Sigma–Aldrich 
Inc. (St. Louis, MO) and was purifi ed by recrystallization from toluene. 
Stannous 2-ethylhexanoate (Sn(Oct) 2 ) and 2-hydroxyethyl methacrylate 
(HEMA) were purchased from Sigma–Aldrich Inc. (St. Louis, MO), and 
were distilled under reduced pressure prior to use. 1,4-Dioxane was 
purchased from Aldrich Chemical (Milwaukee, WI) and was dehydrated 
over molecular sieve. 2,2′-Azoisobutyronitrile (AIBN) was obtained from 
Sigma–Aldrich Inc. (St. Louis, MO) and was recrystallized from ethanol. 
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP), 4-(Dimethylamino)
pyridine (DMAP), triethylamine (TEA) and methacrylic anhydride were 
purchased from Sigma–Aldrich Inc. (St. Louis, MO) and used as received. 
Albumin from bovine serum was also purchased from Sigma-Aldrich 
(St. Louis, MO) and used as received. Deionized water was obtained with 
a Milli-Q water fi lter system from Millipore Corporation (Bedford, MA). 
Cytomodulin and P24 peptides were synthesized by GenicBio Limited, 
Shanghai, China. Thiol-PEG-biotin was purchased from NANOCS Inc. 
(New York, NY). FITC-tagged avidin was purchased from BS Biosciences 
(San Jose, CA). Alpha-Minimum Essential Medium was purchased from 
Invitrogen. Fetal bovine serum (FBS), penicillin–streptomycin, Dulbecco’s 
phosphate-buffered saline (PBS), and trypsin–EDTA were purchased from 
Gibco BRL Products, Life Technologies (Grand Island, NY, USA). 
 Preparation of PHEMA-g-PLLA-acrylic : A series of PHEMA-g-PLLA 
copolymers were synthesized following our previous published 
methods. [ 30 ] Briefl y, PLLA-based macromonomers were synthesized 
using the ring opening polymerization of  L -lactide (LLA) with hydroxyalkyl 
methacrylates (HEMA) as the initiator, and subsequently copolymerized 
with HEMA. The synthesized PLLA-based macromonomers are 
abbreviated as HEMA-PLLAX, where X is the feeding molar percentage 
of HEMA over LLA (e.g., X = 5 means the feeding ratio of HEMA/LLA 
= 5%). The fi nal graft copolymers are abbreviated as PHEMAY- g -PLLAX, 
where Y indicates the feeding molar percentage of macromonomer 
(HEMA-PLLAX) over HEMA (e.g., Y = 10 means the feeding molar ratio of 
HEMA-PLLAX/HEMA = 10%). The X was used to control the graft chain 
length, and the Y was used to control the average backbone sectional 
length between the adjacent two graft chains. These two parameters 
were together used to manipulate the spatial distribution of the acrylic 
groups in the functionalized graft copolymers. A typical functionalization 
reaction of the copolymer PHEMA10-g-PLLA10 (towards PHEMA10-
g-PLLA10-acrylic) is as follows: the copolymer (5 mmol OH, 2.500 g), 
methacrylic anhydride (10 mmol, 1.542 g), DMAP (10 mmol, 1.222 g) 
and TEA (10 mmol, 1.012 g) were dissolved in 1,4-dioxane (200 mL) and 
left overnight stirring at room temperature. The fi ltered solution was 
precipitated by adding ethyl ether, and the polymer precipitate was dried 
under vacuum for 3 days at room temperature. 
 Preparation of FNF-HMS : PHEMA-g-PLLA-acrylic was dissolved in 
20 ml of THF at 50 °C with a concentration of 2.0% (wt/v). Under 
rigorous mechanical stirring (speed 7, MAXIMA, Fisher Scientifi c Inc.), 
glycerol (50 °C) was gradually added into the polymer solution, and 
the stirring continued for another 5 min. The mixture was then quickly 
poured into liquid nitrogen. After 10 min, ice/water mixture was added 
for solvent exchange for 24 h. The spheres were then sieved and washed 
with distilled water several times to remove glycerol residue. The spheres 
were then lyophilized for 2 d. 
 Conjugation with Peptides : The selected peptide (CM or P24) 
(10 equiv) and TCEP (1 equiv) were dissolved in deionized water and 
added to a vial containing the FNF-HMS (1 equiv acrylic unit). The 
contents of the vial were purged with N 2 for 10 min and stirred for 2 h 
at room temperature. The FNF-HMS was then washed extensively using 
deionized water and lyophilized for 2 d. 
 NMR Observation :  1 H spectra of the macromonomers and 
copolymers were recorded with an Inova 400 NMR instrument operating 
at 400 MHz at room temperature using deuterated chloroform (CDCl 3 ) 
as the solvent. 
 GPC Measurements : The molecular weights of the macromonomers 
and copolymers were measured using a Waters gel permeation 
chromatograph (GPC) model 440. Tetrahydrofuran (THF) was used 
as the mobile phase at a fl ow rate of 1.0 mL/min. Molecular weight 
and polydispersity of the copolymers were calibrated with polystyrene 
standards. 
 ATR-FTIR Observation : The ATR-FTIR spectrums of FNF-HMS 
before and after click reaction were obtained with a Perkin Elmer 1800 
FTIR spectroscopy, in the region from 400 to 4000 cm −1 . During the 
measurement, the sample chamber was purged with nitrogen gas to 
reduce moisture and carbon dioxide content. 
 Scanning Electron Microscopy Observation : The surface morphology of 
the microspheres was examined using SEM (Philips XL30 FEG) with an 
accelerating voltage of 10 kV. The samples were coated with gold for 120 s 
using a sputter coater (DeskII, Denton vacuum Inc). 
 Confocal Imaging : To visualize the distribution of the conjugated 
peptides, thiol-PEG-biotin was conjugated to the FNF-HMS under the 
same click reaction conditions as for the conjugation of CM and P24 
peptides. After extensive washing using deionized water, the FNF-HMS-
biotin were treated with 10% w/v BSA solution fi rst, and then with 10% 
w/v FITC-tagged avidin solution to generate FNF-HMS-biotin-avidin. 
The treatment with 10% w/v BSA solution was to prevent unspecifi c 
attachment of FITC-tagged avidin. The FNF-HMS-biotin-avidin were 
examined using confocal laser scanning microscopy (CLSM) (Nikon 
Eclipse C1). FNF-HMS were also treated with BSA and FITC-tagged 
avidin solutions for confocal imaging as the control group. All the 
parameters including the laser intensity and gain were adjusted until 
fl uorescent signals cannot be seen from the control group (FNF-HMS); 
then without changing the settings, FNF-HMS-biotin-avidin were 
observed. 
 Amino Acid Analysis : The sample was fi rst hydrolyzed in 6 N HCl at 
110 °C for 24 h. Then it was reacted with FDNB (1-fl uoro-2, 
4-dinitrobenzene) and was analyzed by high performance liquid 
chromatography (HPLC). The amount of conjugated peptides was 
calculated. 
 Cell Harvest and In Vitro Pellet Culture : Bone marrow-derived 
mesenchymal stem cells (BMSCs) of two-week-old New Zealand White 
rabbits were collected via aspiration from the femoral bone marrow 
using an 18-gauge syringe needle, collecting 10 mL of marrow into 
1000 U of heparin-containing maintenance media (high-glucose 
alpha-MEM (Gibco) containing 10% fetal bovine serum (Gibco) and 
antibiotics (penicillin G, 100 U/mL; streptomycin, 0.1 mg/mL)). The 
marrow was fi ltered through a cell strainer to exclude fatty tissues 
and blood clots, washed with PBS once and fresh media twice, and 
centrifuged at 2000 rpm for 5 min after each wash. Rabbit BMSCs were 
collected and cultured in 75-cm 2 fl asks in maintenance media at 37 °C 
under 5% CO 2 . For the preparation of each pellet, 2 × 10 6 passage-3 
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rabbit BMSCs were trypsinized, mixed with 2 × 10 5 microspheres 
with a diameter of 20–60 µm, and cultured to evaluate chondrogenic 
differentiation. 
 In Vitro Studies of CM10-conjugated FNF-HMS : the following two 
groups were studied: I) BMSCs+FNF-HMS conjugated with CM10 in 
incomplete chondrogenic medium without TGF-β1 (DMEM containing 
1 × 10 −7 mol/L dexamethasone, ITS-A (1000 mg/L insulin, 550 mg/L 
transferrin, 0.67 mg/L sodium selenite, 11000 mg/L sodium pyruvate), 
and 50 µg/mL ascorbate-2-phosphate). II) BMSCs+FNF-HMS in 
incomplete chondrogenic medium without TGF-β1 as the control. The 
cells were cultivated at 37 °C in a humidifi ed atmosphere with 5% CO 2 
for 21 d, changing the medium every 3 d. 
 Subcutaneous Injection of Rabbit BMSCs and Microspheres (FNF-HMS 
Conjugated w/ or w/o CM10 or P24) : All animal procedures were 
carried out under the guidelines of the Institutional Animal Care and 
Use Committee of the University of Michigan. Nude mice (6–8 weeks 
old, NU/NU, Charles River Laboratories USA) were anaesthetized 
with 2.5% isofl urane in balanced oxygen. The microspheres/BMSCs 
suspension was injected into subcutaneous pockets on both sides 
lateral to the dorsal midline using a 25-gauge needle. Each mouse 
received four injections, with each 100 µL injection containing 4 × 10 6 
cells mixed with 4 × 10 5 microspheres for cartilage study or 1.5 × 10 6 
cells and 1 × 10 5 microspheres for bone study. The injections were 
randomly arranged. The tissues were collected after two weeks or fi ve 
weeks, and the fi brous capsules were removed. The samples were 
used for histological and immunohistochemical examinations. 
 Histological and Immunohistological Analyses : For histological 
observation, sections were deparaffi nized, rehydrated, and stained 
with H-E, Safranin O/Fast Green, or von Kossa. For P24 bone study, 
bone tissue samples were decalcifi ed with 10% EDTA for two weeks 
prior to paraffi n embedding for H&E and immunohistochemical (IHC) 
staining. For IHC staining for type II collagen and osteocalcin, following 
deparaffi nization and rehydration, slides were pretreated with pepsin 
solution (Fisher Scientifi c, USA) for 15 min, incubated with the primary 
antibody (mouse type II collagen antibody or rabbit osteocalcin antibody, 
both from Santa Cruz Biotechnology, Santa Cruz, CA) at 1:100 dilutions 
for 1 h and prepared using a cell & tissue staining kit (R&D Systems 
Inc., Minneapolis, MN, USA). All sections were counterstained with 
hematoxylin. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author. 
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